Jung-Kyu Han Selected Research

Jung-Kyu Han Research Topics

Disease

29	Myocardial Infarction 11/2023 - 01/2013
22	Thrombosis (Thrombus) 10/2023 - 01/2013
20	Hemorrhage 10/2023 - 09/2015
17	Acute Coronary Syndrome 10/2023 - 01/2014
11	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 09/2015
9	Stroke (Strokes) 10/2023 - 09/2015
7	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 09/2008
6	Death (Near-Death Experience) 10/2023 - 01/2013
5	Diabetes Mellitus 10/2023 - 01/2019
5	Chronic Renal Insufficiency 10/2023 - 01/2014
4	ST Elevation Myocardial Infarction 06/2022 - 01/2020
3	Hypertension (High Blood Pressure) 01/2024 - 01/2018
3	Ischemic Stroke 10/2023 - 10/2020
3	Coronary Stenosis (Coronary Artery Stenosis) 01/2023 - 10/2013
3	Pathologic Constriction (Stenosis) 01/2021 - 10/2013
2	Dyslipidemias (Dyslipidemia) 01/2024 - 01/2018
2	Cardiogenic Shock 11/2023 - 04/2015
2	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2014
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2020 - 10/2019
2	Vascular Diseases (Vascular Disease) 01/2016 - 09/2014
2	Inflammation (Inflammations) 09/2015 - 01/2013
1	Essential Hypertension 01/2024
1	Peripheral Arterial Disease 10/2023
1	Heart Failure 10/2023
1	Spasm (Spasms) 02/2023
1	Obesity 01/2023
1	Morbid Obesity 01/2023
1	Overweight 01/2023
1	Left Ventricular Dysfunction 10/2022
1	Atrioventricular Block 09/2021
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2021
1	Sarcopenia 09/2020
1	Endocarditis 01/2020
1	Hypersensitivity (Allergy) 10/2019
1	Anemia 07/2019
1	Wounds and Injuries (Trauma) 01/2016
1	AIDS-Related Complex (ARC) 09/2015
1	Ischemia 10/2013
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 06/2013
1	Hypoxia (Hypoxemia) 09/2008
1	Corneal Neovascularization 09/2008

Drug/Important Bio-Agent (IBA)

9	Clopidogrel (Plavix)FDA Link 10/2023 - 01/2018
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 10/2020
9	Prasugrel Hydrochloride FDA Link 10/2023 - 09/2015
8	omega-Chloroacetophenone (Mace)IBA 10/2023 - 10/2013
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2023 - 10/2017
6	PolymersIBA 10/2023 - 09/2015
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2024 - 01/2018
2	CreatinineIBA 09/2020 - 07/2019
2	Contrast MediaIBA 01/2020 - 10/2019
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 06/2013
1	oxidized low density lipoproteinIBA 01/2024
1	telmisartan amlodipine combination FDA Link 01/2024
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2023
1	LDL CholesterolIBA 05/2023
1	CalciumIBA 02/2023
1	MB Form Creatine KinaseIBA 01/2023
1	ElementsIBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Cystatin CIBA 09/2020
1	Glucose (Dextrose)FDA LinkGeneric 08/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	iodixanol (Visipaque)FDA Link 10/2019
1	ioversol FDA Link 10/2019
1	C-Reactive ProteinIBA 01/2019
1	Telmisartan (Micardis)FDA Link 01/2018
1	TicagrelorIBA 01/2018
1	matrigelIBA 01/2016
1	BESIBA 09/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Sirolimus (Rapamycin)FDA Link 10/2013
1	Everolimus FDA Link 10/2013
1	GW 501516IBA 09/2008
1	4- (3- (2- propyl- 3- hydroxy- 4- acetyl)phenoxy)propyloxyphenoxy acetic acidIBA 09/2008
1	PPAR deltaIBA 09/2008

Therapy/Procedure

31	Percutaneous Coronary Intervention 10/2023 - 04/2015
28	Stents 10/2023 - 01/2013
13	Therapeutics 01/2024 - 10/2017
13	Drug-Eluting Stents 01/2023 - 11/2014
3	Transcatheter Aortic Valve Replacement 09/2021 - 01/2020
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2023 - 01/2023
2	Drug Tapering 04/2022 - 01/2022
2	Intra-Arterial Injections 01/2020 - 10/2019
1	Extracorporeal Membrane Oxygenation 11/2023
1	Secondary Prevention 10/2023
1	Duration of Therapy 10/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2014
1	Limb Salvage 09/2008